Rubedo Life Sciences: Funding, Investors & Team (Sep 2026)
Rubedo Life Sciences is a biopharmaceutical company focused on developing a range of innovative therapies designed to target cells responsible for chronic age-related diseases. Through their ALEMBIC drug discovery platform, the company has created unique small molecules that specifically target senescent cells, which play a crucial role in various chronic conditions such as pulmonary, dermatological, oncological, neurodegenerative, and fibrotic diseases. The leadership team at Rubedo consists of industry experts with a wealth of experience in drug development and commercialization, spanning from major pharmaceutical companies to smaller biotech firms.
Rubedo Life Sciences has raised $53.5M across 3 funding rounds on record, the most recent a Series A of $40.0M announced in Apr 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Rubedo Life Sciences Company Profile and Key Stats
Latest funding round on record: Apr 2024.
Rubedo Life Sciences Funding Rounds
Rubedo Life Sciences raised $12.0M in an undisclosed round announced in Dec 2020.
2.2 years later, an undisclosed round of $1.5M was announced in Feb 2023.
1.2 years later, a Series A of $40.0M was announced in Apr 2024.
Rubedo Life Sciences Founders and Leadership Team
Contact details for the Rubedo Life Sciences team: 2 of 2 have an email address on file.
Start 14-day free trial →Rubedo Life Sciences Funding Compared to Other Biotechnology Startups
Rubedo Life Sciences' latest round of $40.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Rubedo Life Sciences in Biotechnology and Sunnyvale
Companies Similar to Rubedo Life Sciences
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Rubedo Life Sciences Funding FAQs
What does Rubedo Life Sciences do?
Rubedo Life Sciences is a biopharmaceutical company focused on developing a range of innovative therapies designed to target cells responsible for chronic age-related diseases. Through their ALEMBIC drug discovery platform, the company has created unique small molecules that specifically target senescent cells, which play a crucial role in various chronic conditions such as pulmonary, dermatological, oncological, neurodegenerative, and fibrotic diseases. The leadership team at Rubedo consists of industry experts with a wealth of experience in drug development and commercialization, spanning from major pharmaceutical companies to smaller biotech firms.
How much funding has Rubedo Life Sciences raised?
Rubedo Life Sciences has raised $53.5M across 3 rounds on record. The most recent is a Series A of $40.0M announced in Apr 2024.
When did Rubedo Life Sciences last raise funding?
Rubedo Life Sciences' most recent funding round on record is a Series A of $40.0M, announced in Apr 2024.
Who founded Rubedo Life Sciences?
FundedIQ lists Julian Klein (Founder) at Rubedo Life Sciences.
Who is the CEO of Rubedo Life Sciences?
Marco Quarta is listed as CEO at Rubedo Life Sciences.
Where is Rubedo Life Sciences headquartered?
Rubedo Life Sciences is based in Sunnyvale, California, United States.
How many employees does Rubedo Life Sciences have?
Rubedo Life Sciences is in the 11-50 employee band.
How does Rubedo Life Sciences' funding compare to other Biotechnology startups?
Rubedo Life Sciences' latest round of $40.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Rubedo Life Sciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Rubedo Life Sciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.